Navigation Links
Alk-Phos Stabilizing Diluent from ScyTek Laboratories

ProductsAlk-Phos Stabilizing Diluent from ScyTek Laboratories
Company ScyTek Laboratories
Item Alk-Phos Stabilizing Diluent
Price $1,379.00
Description This reagent is formulated specifically for Alkaline Phosphatase conjugates. The product insures consistently high levels of activity for both the enzyme and the antibody following long-term storage at final dilution. This product has been chemically engineered to increase conjugate stability providing the customer a longer shelf life, resistance to various shipping conditions and storage temperatures. Alk-Phos Stabilizing Diluent is filtered at 0.2 um and reinforced with a non-mercury or azide-free preservative. Inquire about custom vialing, labeling, kit assembly and drop shipping.
Info ScyTek LaboratoriesScyTek Laboratories
205 South 600 West
Logan, UT 84321
Customer Service: (800) 729-8350
Fax Number: (435) 755-0015
Web Site: http://www.scytek.com/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Alk-Phos Stabilizing Diluent from ScyTek Laboratories
2. Peroxidase, Horseradish, Conjugate-Stabilizing Solution from Calbiochem
3. Conjugate Stabilizing Diluent Alkaline Phosphatase from Meridian Life Science, Inc.
4. Conjugate Stabilizing Diluent HRP from Meridian Life Science, Inc.
5. HRP Stabilizing Diluent (Phosphate Buffered) without BSA from ScyTek Laboratories
6. HRP Stabilizing Diluent (MOPS Buffered) from ScyTek Laboratories
7. HRP Stabilizing Diluent (Phosphate Buffered) without BSA from ScyTek Laboratories
8. HRP Stabilizing Diluent (Phosphate Buffered) from ScyTek Laboratories
9. HRP Stabilizing Diluent (Phosphate Buffered) from ScyTek Laboratories
10. ELISA Antibody Diluent-Rabbit Polyclonal from AbD Serotec
11. HRP Monoclonal-Goat Diluent - 5X Concentrate from BioFX Laboratories, Inc.
...
Request Info...
Human RUNX2/CBFA1 MAb (Clone 232902)...
... Peroxidase Conjugate, 2 ml. ... enzyme molecules for use ... situ hybridization applications.High specificity ... Labeling & Detection, Protein ...
Biology Products:
(Date:10/16/2014)... infections and worldwide claims the lives of 160,000 ... University have succeeded in developing a promising vaccination ... , Xavier Saelens (VIB/UGent): "We discovered a new ... development of a novel approach to vaccination against ... small children and elderly people." , RSV: ...
(Date:10/15/2014)... a non-traditional biophysics textbook and it describes how life ... of discovery into biological systems and provides an understanding ... is about how our genes make proteins that control ... cells in an organism. It quantifies the principles of ... be found on both large and small scales. The ...
(Date:10/15/2014)... 44th Rosenstiel Award for Distinguished Work in Biomedical Science ... mechanisms of genomic instability and its implications for the ... alumnus to win the Rosenstiel Award; the first, Rod ... is the Charles A. Janeway Professor of Pediatrics and ... investigator at the Howard Hughes Medical Institute at Boston ...
Breaking Biology News(10 mins):New perspectives for development of an RSV vaccine 2New book about life as seen from physics 2Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2
... turkeys died in Britain of cancer of the liver. Eventually, ... of aflatoxin as the cause of this mysterious 'turkey X' ... the most virulent natural carcinogenic substances. , The tasteless toxin ... hot, arid regions, in the south-west of the US and ...
... of people in southwest China suffer from potentially-crippling fluoride ... coal, say researchers. , The findings, from a study ... that the disease was caused by people burning fluoride-rich ... this belief, last year, the Chinese authorities invested 34 ...
... what many scientists thought, genetically modified (GM) corn has ... Mexico. , After analyzing tens of thousands of seeds ... from Mexico and the United States found no evidence ... surprised the researchers, said Allison Snow, a professor of ...
Cached Biology News:Corn grain mould used as pesticide 2Fluoride poisoning in China due to clay, not coal 2Genetically modified maize not found in southern Mexico 2
(Date:10/22/2014)... 2014 Nuvilex, Inc. (OTCQB: NVLX) – According ... worldwide are living with diabetes, with  that number expected ... global market for diabetes treatments is approximately $500 billion.  ... died from pancreatic cancer.  Pancreatic cancer is the fourth ... the United States , and according ...
(Date:10/20/2014)... 20, 2014 The report “Pharmacy ... Systems, Packaging and Labeling Systems, Table-top Counters) by ... Global Forecasts & Trends to 2019” analyzes and ... in North America, Europe, Asia-Pacific, and the Rest ... tables and 30 figures spread through 300 pages ...
(Date:10/20/2014)... PARK, Calif. , Oct. 20, 2014 /PRNewswire/ ... today that the Company has signed a Notice ... of Regenerative Medicine (CIRM), effective October 1, 2014.  ... Clinical Development payments and the release of additional ... million CIRM grant award for clinical development of ...
(Date:10/20/2014)... 20, 2014  GenVec, Inc. (NASDAQ: GNVC ) ... Ph.D., from its board of directors effective on October 24, ... and served as its chairman from June 2006 to November ... and Corporate Governance and Audit Committees of the board.  ... decade of dedicated service to GenVec, and its stockholders," said ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4Zola P. Horovitz To Retire From GenVec Board 2